Serum metabolomics as biomarkers to differentiate early from metastatic disease and predict relapse in elderly colorectal cancer (CRC) patients.

10042Background: Adjuvant chemotherapy improves survival in stage II and III CRC, although a significant proportion of patients (pts) are cured by surgery alone. Improved risk stratification is req...